Metraipolis › archive › dc_3a8726ab76cc

Case Report: Prognostic evaluation of immunotherapy in two patients with SMARCA4-UT using TCR as a new marker — Europe PMC PMID:41142791

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41142791
DOI
10.3389/fimmu.2025.1618118
License (as archived)
solo-consultazione
Archived
2026-11-09T16:53:39.004Z
SHA-256 of the archived text
5f9da950afce4b3386b1b9a92ff15ca41c08d01355ba4248a7a0f59dbb10bfc3
Stable URL of this page
https://metraipolis.com/documento/dc_3a8726ab76cc

How to cite

Case Report: Prognostic evaluation of immunotherapy in two patients with SMARCA4-UT using TCR as a new marker — Europe PMC PMID:41142791 — Europe PMC (en), https://europepmc.org/article/MED/41142791 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3a8726ab76cc (Metraipolis archive dc_3a8726ab76cc, sha256 5f9da950afce4b3386b1b9a92ff15ca41c08d01355ba4248a7a0f59dbb10bfc3)
BibTeX
@misc{dc3a8726ab76cc,
  title = {Case Report: Prognostic evaluation of immunotherapy in two patients with SMARCA4-UT using TCR as a new marker — Europe PMC PMID:41142791},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41142791},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3a8726ab76cc; sha256 5f9da950afce4b3386b1b9a92ff15ca41c08d01355ba4248a7a0f59dbb10bfc3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41142791. Agents can read the archived copy with the MCP tool read_document.